Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 4 3Phase 3 3Phase NA 2

Status

Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 2

Conditions

Seizures 2Brain Neoplasms 2Postoperative Seizures After Brain Tumor Surgery 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 183Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × OTHER × Levetiracetam × Clear all
NCT07239115 2026-05-28

PREVENT

Beijing Tiantan Hospital

Phase 3 Recruiting
558 enrolled

Postoperative Seizures After Brain Tumor Surgery

NCT06442748 2026-02-13

LIBRA

Tata Memorial Centre

Phase 3 Recruiting
604 enrolled
CNS

Brain Neoplasms, Seizures

NCT05897658 2024-10-23

LeviTaTe Pilot

Hamilton Health Sciences Corporation

Phase 3 Not yet recruiting
70 enrolled
CNS

Brain Neoplasms, Seizures

Data powered by HemOnc (CC BY 4.0) Colophon âš¡